Series A · 2026-11-18 · AI
Boltz raises $110.0M
76
AI Score
Amount
$110.0M
Round
Series A
Lead
Bessemer
HQ
—
Why it matters: Boltz's $110M Series A shows investors backing domain-specific drug discovery models, with details on how BoltzMol-1 cuts candidate screening from hundreds of thousands of molecules to a few dozen.
Boltz PBC, a startup building AI models for pharmaceutical research, raised a $110 million Series A led by Bessemer.
- Participants:
- Andreessen Horowitz, Amplify Partners, Zetta Venture Partners, Obvious Ventures, Greycroft, F-Prime Capital, Hummingbird, Benchling
- Source:
- SiliconANGLE ↗ · Midu summary
Deal Dossier PRO
Pro feature
Deal Dossier for Boltz
Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.
Generate dossier — ProFigures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).
More deals with Bessemer
Recent AI rounds
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing